RNAZ TransCode Therapeutics, Inc. logo

RNAZ TransCode Therapeutics, Inc.

Healthcare
$5.44+0.00%OpenMarket Cap: $5.2M

As of 2026-05-26

Insider Statistics (Q2 2023)

Acquisitions

12

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+1,255,107

Shares Acquired

1,255,107

Shares Disposed

0

Total Bought ($)

$4.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Mon Dec 22STOVER JACK Edirector: Sell0$0.000
Mon Dec 22CZEREPAK ELIZABETHdirector: Sell0$0.000
Tue Jun 18Marquet MagdadirectorSell70,000$1.2070,000
Tue Jun 18Manting ErikdirectorSell70,000$1.2070,000
Tue Jun 18Fitzgerald Thomas Adirector, officer: Interim CEO, CFOSell650,000$1.20650,000
Tue Jun 18Calais PhilippedirectorSell70,000$1.2070,000
Mon Oct 02Fitzgerald Thomas Adirector, officer: Chief Financial OfficerBuy49,350$0.5156,318
Mon Oct 02Dudley Robert Michaeldirector, officer: Chief Executive OfficerBuy98,000$0.51180,262
Thu Jun 22Dudley Robert Michaeldirector, officer: Chief Executive OfficerBuy12,000$2.6582,262
Thu Jun 22Dudley Robert Michaeldirector, officer: Chief Executive OfficerBuy6,607$2.5570,262